Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma

Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran

Clin Mol Hepatol. 2016;22(4):450-457. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0036

View: 8984 Download: 157 Web of Science: 6 Crossref: 5

Liver Imaging

Composite liver tumors: A radiologic-pathologic correlation

Megha Nayyar, David K. Imagawa, Temel Tirkes, Aram N. Demirjian, Roozbeh Houshyar, Kumar Sandrasegaran, Chaitali S. Nangia, Tara Seery, P Bhargava, Joon II Choi, Chandana Lall

Clin Mol Hepatol. 2014;20(4):406-410. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.406

View: 7762 Download: 59 Web of Science: 3 Crossref: 3

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib

Joon-Il Choi, David K Imagawa, Priya Bhosale, Puneet Bhargava, Temel Tirkes, Tara E Seery, Chandana Lall

Clin Mol Hepatol. 2014;20(2):218-222. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.218

View: 6451 Download: 78 Web of Science: 11 Crossref: 12

Viewed By 5556	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4759	MAFLD: How is it different from NAFLD?
Viewed By 4480	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3675	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3650	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Author :

Author index